ERBB2 and breast carcinoma: The TCGA, METABRIC and Memorial Sloan Kettering (MSK) datasets were explored via cBioPortal for in silico analyses of the mutational landscape of primary or metastatic biopsies of ER+/HER2‐ breast carcinomas.